Steady trend of KOLs denying/downplaying CVD/malignancy risk from JAKs
1. Find a way to explain away ORAL-SURVEILLANCE (I can’t!)
2. Decide RCTs don’t matter (foolish)
3. Admit you just really like JAKs & +/- your pharma rep (🥺)
Pick one, or please stop. The risk is real.
@Janetbirdope I think we have in mind all complications but it’s hard to say a name to the patient and also it is hard when you have to talk to GP that needs a disease name.